- €41.80m
- €80.66m
- €131.48m
- 30
- 53
- 38
- 31
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | 12.15 | ||
PEG Ratio (f) | n/a | ||
EPS Growth (f) | n/a | ||
Dividend Yield (f) | n/a |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | 1.43 | ||
Price to Tang. Book | n/a | ||
Price to Free Cashflow | n/a | ||
Price to Sales | 0.3 | ||
EV to EBITDA | n/a |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | -13.79% | ||
Return on Equity | -24.97% | ||
Operating Margin | -6.01% |
Financial Summary
Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | €m | 37.41 | 64.09 | 82.48 | 116.31 | 131.48 | 168.6 | 202.3 | 39.65% |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
Talea Group SpA is an Italy-based company specialized healthcare and wellness products. It manages an e-shop and different stores in Tuscany with a wide offering, which includes cosmetics, pharmaceuticals, medical devices, food supplements and alternative medicines, among others. The Company is active locally.
Directors
- Last Annual
- December 31st, 2023
- Last Interim
- June 30th, 2024
- Incorporated
- January 1st, 1970
- Public Since
- July 29th, 2019
- No. of Employees
- 235
- Sector
- Software & IT Services
- Industry
- Technology
- Exchange
Borsa Italiana
- Shares in Issue
- 8,495,377

- Address
- Via Marco Polo 190, VIAREGGIO, 55049
- Web
- https://taleagroupspa.com/
- Phone
- +39 800953333
- Contact
- Alberto Maglione
- Auditors
- Deloitte & Touche SpA
Upcoming Events for TALEA
Similar to TALEA
Almawave SpA
Borsa Italiana
Cy4gate SpA
Borsa Italiana
Cyberoo SpA
Borsa Italiana
Datrix SpA
Borsa Italiana
Digital Bros SpA
Borsa Italiana
FAQ
As of Today at 22:34 UTC, shares in Talea SPA are trading at €4.92. This share price information is delayed by 15 minutes.
Shares in Talea SPA last closed at €4.92 and the price had moved by -26.09% over the past 365 days. In terms of relative price strength the Talea SPA share price has underperformed the FTSE Global All Cap Index by -33.12% over the past year.
The overall consensus recommendation for Talea SPA is Strong Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreTalea SPA does not currently pay a dividend.
Talea SPA does not currently pay a dividend.
Talea SPA does not currently pay a dividend.
To buy shares in Talea SPA you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of €4.92, shares in Talea SPA had a market capitalisation of €41.80m.
Here are the trading details for Talea SPA:
- Country of listing: Italy
- Exchange: MIL
- Ticker Symbol: TALEA
Based on an overall assessment of its quality, value and momentum Talea SPA is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Talea SPA is €10.00. That is 103.25% above the last closing price of €4.92.
Analysts covering Talea SPA currently have a consensus Earnings Per Share (EPS) forecast of -€0.25 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Talea SPA. Over the past six months, its share price has underperformed the FTSE Global All Cap Index by -36.96%.
As of the last closing price of €4.92, shares in Talea SPA were trading -17.19% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Talea SPA PE ratio based on its reported earnings over the past 12 months is 12.15. The shares last closed at €4.92.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
We do not have data on Talea SPA's directors